Archive · 13 Sep 2025
Gene Sequencing Advances in Rare Disease Diagnosis and Treatment
Imagine a tiny problem in your body's instruction manual (DNA) that can cause rare diseases.
Scientists are now using advanced technology to read and fix these manuals.
They can quickly find the mistakes (mutations) in a person's DNA that cause these diseases.
This helps doctors diagnose and treat these conditions much faster, sometimes even before symptoms start.
One company, GeneDx, is leading the way by sequencing DNA and looking for these errors.
They are also working on gene therapies to fix or replace faulty genes.
This means that children born with rare diseases, who might not have lived long before, now have a chance to live a healthier life.
More states are providing this testing to catch genetic problems early on.
Gene sequencing and editing are enabling new treatments for rare genetic diseases.
GeneDx sequences DNA to find mutations responsible for thousands of disorders.
Newborn screenings can identify genetic conditions, potentially leading to early interventions.
Expanding access to genetic screening could save healthcare costs and improve patient outcomes.
Companies are working on gene therapies for rare disorders.
- Who
- KJ Muldoon, GeneDx, and individuals with rare diseases
- What
- Advances in gene sequencing for diagnosis and treatment of rare diseases
- When
- August 2024 (KJ Muldoon's birth)
- Where
- Children’s Hospital of Philadelphia and University of Pennsylvania's medical school; New York Presbyterian hospital system
- Why
- To diagnose and treat rare genetic diseases, improving patient outcomes
- Company
- GeneDx
- CEO
- Katherine Stueland
- FDA Estimate
- 30 million Americans with rare diseases
- GeneDx Test Cost
- $3,700
- Positive Rate of Newborn Screening
- 3.7%
- 23andMe Bankruptcy
- January 2024